SCHEMBL9268606

SCHEMBL9268606

OC1CCCCC1Sc1cc(Cl)ccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.46
DDB1 Q16531 1/20 0.43
CRBN Q96SW2 1/20 0.43
HTT P42858 3/20 0.43
TSHR P16473 3/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 3/20 0.37
CTSK P43235 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TAS1R2 Q8TE23 1/20 0.37
GAA P10253 1/20 0.36
AGTR1 P30556 1/20 0.36
SLC18A3 Q16572 1/20 0.35
CYP2C19 P33261 3/20 0.35
ALDH1A1 P00352 4/20 0.34
CYP2C9 P11712 2/20 0.34
CYP3A4 P08684 2/20 0.34
HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9268602 1.00 TDP1 (0.46) TDP1DDB1CRBNHTTTSHR
SCHEMBL9268599 1.00 TDP1 (0.46) TDP1DDB1CRBNHTTTSHR
SCHEMBL9264328 0.80 RAB9A (0.46) TDP1HTTTSHRRAB9ANPC1
SCHEMBL9264331 0.80 RAB9A (0.46) TDP1HTTTSHRRAB9ANPC1
SCHEMBL9264336 0.80 RAB9A (0.46) TDP1HTTTSHRRAB9ANPC1
SCHEMBL1496659 0.76 HTT (0.47) TDP1DDB1CRBNHTTTSHR
SCHEMBL9263462 0.76 HTT (0.47) TDP1DDB1CRBNHTTTSHR
SCHEMBL9263459 0.76 HTT (0.47) TDP1DDB1CRBNHTTTSHR
SCHEMBL9487364 0.76 DDB1 (0.48) TDP1DDB1CRBNTSHRNPC1
SCHEMBL9278863 0.76 TDP1 (0.51) TDP1DDB1CRBNHPGDCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5476944-A Inhibitors or stimulators of superoxide generation; may also inhibit cyclooxygenase and/or 5-lipoxygenase; useful in therapeutic or prophylactic treatment of disease conditions G. D. SEARLE & CO. (US) 1995-12-19 US disclosed
EP-0613463-A1 DERIVATIVES OF CYCLIC PHENOLIC THIOETHERS AS INHIBITORS OR STIMULATORS OF SUPEROXIDE GENERATION G.D. SEARLE & CO. (US) 1994-09-07 EP disclosed
WO-1993010087-A1 DERIVATIVES OF CYCLIC PHENOLIC THIOETHERS AS INHIBITORS OR STIMULATORS OF SUPEROXIDE GENERATION G.D. SEARLE & CO. (US) 1993-05-27 WO disclosed